Tick-borne encephalitis virus (TBEV) is a zoonotic disease agent that causes severe encephalitis in 36 humans. The envelope protein E of TBEV has one N-linked glycosylation consensus sequence, but 37 little is known about the biological function of the N-linked glycan. In this study, the function of 38 protein E glycosylation was investigated using recombinant TBEV with or without the protein E 39 N-linked glycan. Virion infectivity was not affected after removing the N-linked glycans using 40 N-glycosidase F. In mammalian cells, loss of glycosylation affected the conformation of protein E 41 during secretion, reducing the infectivity of secreted virions. Mice subcutaneously infected with 42 TBEV lacking protein E glycosylation showed no signs of disease, and viral multiplication in 43 peripheral organs was reduced relative to that with the parental virus. In contrast, loss of 44 glycosylation did not affect the secretory process of infectious virions in tick cells. Furthermore, 45 inhibition of transport to the Golgi apparatus affected TBEV secretion in mammalian cells, but not in 46 tick cells, indicating that TBEV was secreted through an unidentified pathway after synthesis in 47 endoplasmic reticulum in tick cells. These results increase our understanding of the molecular 48 mechanisms of TBEV maturation. 49 50 51 52 53 Tick-borne encephalitis virus (TBEV), a member of the genus Flavivirus within the family 54 Flaviviridae, causes tick-borne encephalitis (TBE) in humans. TBE is endemic in Europe, Russia, 55
Introduction
Oshima-IC-ΔEg was not (Fig. 5a ). In contrast to BHK cells, ISE6 cells infected with Oshima-IC-pt 140 and with -ΔEg showed no difference in viral multiplication (Fig. 5b) or the amount of secreted 141 protein E detected using anti-E monoclonal antibodies recognizing protein E conformational epitopes 142 ( Fig. 5c ). To investigate whether the different incubation temperature between mammalian cells 143 (37°C) and tick cells (34°C) affected the stability of the unglycosylated E protein, the virus 144 multiplication was examined in BHK cells at 34°C. As was observed with the incubation at 37°C 145 ( Fig. 2a ), a lower titer of infectious virus was secreted from cells infected with Oshima-IC-ΔEg 146 compared with Oshima-IC-pt in BHK cells at 34°C (supplementary figure 1). These results indicate 147 that the glycosylation of protein E was not important for viral multiplication or secretion in tick cells. 148 Flaviviruses are generally thought to bud into the ER of virus-infected cells, followed by transport in 149 vesicles to the Golgi complex and release by exocytosis via the trans-Golgi network (Lindenbach et 150 al., 2007; Mackenzie & Westaway, 2001) . To analyze the differences in the roles of TBEV 151 glycosylation in maturation and secretory processes between BHK and ISE6 cells, the effects of 152 inhibitors of cellular secretory mechanisms were investigated in virus-infected cells. Tunicamycin 153 was used to inhibit the glycosylation of newly synthesized glycoproteins (Elbein, 1987) . 154 Tunicamycin treatment of BHK cells infected with Oshima-IC-pt or -ΔEg reduced the secreted virus 155 titer, and the reduction was the same for Oshima-IC-pt and -ΔEg (Fig. 6a ). In ISE6 cells infected 156 with Oshima-IC-pt or -ΔEg, tunicamycin treatment did not reduce the virus titer of Oshima-IC-pt or 157 ΔEg (Fig. 6b ). This suggests that the glycosylation of newly synthesized glycoproteins, including 158 protein E and other glycoproteins such as protein prM or NS1, is important for the maturation and 159 secretion of TBEV in mammalian BHK cells, but not in tick ISE6 cells. The secretion of infectious 160 virions was further analyzed using brefeldin A (BFA), which interferes with anterograde transport 161 from the endoplasmic reticulum to the Golgi apparatus (Fujiwara et al., 1988) . BFA treatment of 162 infected BHK cells significantly reduced the titers of secreted Oshima-IC-pt and -ΔEg, whereas BFA 163 treatment of infected ISE6 cells did not reduce the virus titers ( Fig. 6a and b ). The glycosylation of 164 the E proteins of Oshima-IC-pt was examined in ISE6 cells treated with tunicamycin or BFA ( Fig.   165 6c). Tunicamycin treatment inhibited the glycosylation of the E proteins while The E proteins were 166 still glycosylated after BFA treatment. Thus, the E proteins were naturally glycosylated in ER after 167 synthesis in ISE6 cells, but it was not necessary for virus secretion. Furthermore, the secretion of 168 TBEV in tick ISE6 cells was independent of the traditional secretory pathway through the Golgi 169 apparatus.
171
The effect of the glycosylation on the virulence in mice 172 The effect of glycosylation on pathogenicity was examined in a mouse model. Five-week-old 173 female C57BL/6J mice were infected subcutaneously with Oshima-IC-pt or -ΔEg at 10 5 pfu/mouse 174 and monitored for 28 days (Fig. 7) . All mice infected with Oshima-IC-pt showed general signs of 175 illness such as hunched posture, ruffled fur, and general malaise; one mouse died. However, no mice infected with Oshima-IC-ΔEg showed signs of illness or died.
177
To examine the correlation between disease development and viral replication in organs, viral 178 loads in the blood, spleen, and brain were compared between mice inoculated with 10 5 pfu of 179 Oshima-IC-pt and 10 5 pfu of Oshima-IC-ΔEg (Fig. 8 ). The levels of transient viremia and 180 multiplication in the spleen were lower in mice infected with Oshima-IC-ΔEg than in those infected 181 with Oshima-IC-pt. In the brain, the virus was detected from 6 days post-infection in mice infected 182 with Oshima-IC-pt, while a low titer of virus was detected in only one mouse at 12 days 183 post-infection with Oshima-IC-ΔEg. These data indicate that the Oshima-IC-ΔEg virus cannot 184 multiply efficiently in organs, leading to a loss of virulence in mice.
185
Similar high titers of neutralizing antibodies (>320) were observed in mice infected with 186 Oshima-IC-pt or with Oshima-IC-ΔEg at 12 days post-infection (data not shown), suggesting that 187 lack of the N-linked glycan on protein E did not affect the induction of neutralizing antibodies. immunogenicity, and pathogenicity (Vigerust & Shepherd, 2007) . In this study, we used an infectious 193 TBEV cDNA clone to generate infectious virus with or without protein E N-linked glycan and 194 investigated specific phenotypic changes in mammalian and tick cells.
195
The defect in protein E glycosylation reduced the secretion of infectious virions in mammalian 196 cells. In studies of West Nile virus and dengue virus, a defect in glycosylation caused similar 197 reductions in the release of infectious virions (Hanna et al., 2005; Lee et al., 2010; Li et al., 2006). 198 Although the total level of secreted protein E remained constant, the conformational structure of 199 protein E was affected by the lack of glycosylation, resulting in reduced virion infectivity. However, 200 cleavage of the N-linked glycan after secretion did not affect virion infectivity in mammalian cells.
201
These results indicate that glycosylation is important in retaining the conformational structure of 202 protein E, which is necessary for virion infectivity during the intracellular secretory process in 203 mammalian cells. In the endoplasmic reticulum, two homologous resident lectins (calnexin and 204 calreticulin) bind N-linked core glycans and promote proper folding of glycoproteins (Ellgaard et al., 205 1999) . It is known that the loss of glycosylation alters West Nile virus virion stability at mildly acidic 206 pHs (Beasley et al., 2005) . Defects in protein E glycosylation may affect the proper folding and/or 207 stability of virions, reducing the infectivity of TBEV in mammalian cells.
208
In the mouse model, protein E glycosylation affected TBEV pathogenicity. TBEV without 209 protein E glycosylation did not multiply efficiently in peripheral organs, and eventually the virus 210 could not enter the brain or cause disease in mice. Similarly, reduced neuroinvasiveness due to a 211 defect in glycosylation was reported in a West Nile virus study (Beasley et al., 2005; Shirato et al., 212 2004). The mechanism of neuroinvasiveness of TBEV is unclear, but it has been reported that 213 efficient viral multiplication in peripheral organs is required for TBEV entry into the brain (Mandl, The lack of protein E glycosylation did not affect the TBEV secretory process in tick cells, unlike 221 in mammalian cells. Furthermore, the inhibition of transport from the endoplasmic reticulum to the 222 Golgi apparatus did not affect TBEV multiplication in tick cells. In a previous report, nascent TBEV 223 particles were observed inside vacuoles, and free nucleocapsids were seen in the cytosol or attached 224 to the membrane of virus particle-containing vacuoles in tick cells, whereas viral particles appeared 225 in the endoplasmic reticulum, Golgi apparatus, and secretory pathway in mammalian cells (Senigl et 226 11 al., 2006) . Taken together, our data suggest that TBEV secretion in tick cells occurs through an 227 unidentified mechanism different from the traditional secretory pathway through the Golgi apparatus.
228
Glycosylation-independent virus secretion was observed only in TBEV-infected tick cells. 229 However, studies of mosquito-borne flavivirus have shown that glycosylation of protein E is (Nuttall & Labuda, 2003) . In persistent tick infections, viruses are thought to multiply 236 regardless of the glycosylation of the E proteins. It is possible that because TBEV with glycosylated 237 protein E has more effective transmission from tick vectors to mammals, it had a selective advantage 238 during viral evolution.
239
In summary, we generated recombinant TBEV with or without glycosylated protein E. Deletion 240 of the glycosylation site affected the maturation of TBEV infectious virions in mammalian cells and 241 reduced TBEV virulence in mice. Our results suggest that TBEV is secreted in a 242 glycosylation-independent manner in tick cells. Overall, these results increase our understanding of 243 the molecular mechanism of TBEV maturation and can be applied to attenuate TBEV infection. which nucleotides for the glycosylation site in protein E were mutated as shown in Fig. 1a .
257
RNA was transcribed from the Oshima-IC plasmid using a mMESSAGE mMACHINE SP6 kit 258 (Life Technology. Carlsbad, CA, USA) and was transfected into BHK cells using TransIT-mRNA 259 (Mirus Bio, Madison, WI, USA), as described previously (Yoshii et al., 2011; Yoshii et al., 2004) . Titration and neutralization test 316 For titration, cell monolayers prepared in 12-well plates were incubated with serial dilutions of 317 the virus for 1 h, overlaid with minimal medium containing 2% FBS and 1.5% carboxymethyl 318 cellulose, and incubated for 5 days. After incubation, the cells were fixed and stained with 0.25% 319 crystal violet in 10% buffered formalin. Plaques were counted and expressed as pfu ml -1 . For the 320 neutralization test, serum samples that induced a 50% reduction in Oshima-IC-pt plaque formation 321 were examined. Takashima, I., Morita, K., Chiba, M., Hayasaka, D., Sato, T., Takezawa, C., Igarashi, A., Kariwa, H., 410 Yoshimatsu, K., Arikawa, J. & Hashimoto, N. (1997) . A case of tick-borne encephalitis in Japan 411 and isolation of the the virus. Journal of clinical microbiology 35, 1943-1947. 
